Intravenous administration of CpG7909 lipoplex enhances anti-PD1 immunotherapy by modulating the tumor microenvironment and inducing durable tumor regression.
Saved in:
| Title: | Intravenous administration of CpG7909 lipoplex enhances anti-PD1 immunotherapy by modulating the tumor microenvironment and inducing durable tumor regression. |
|---|---|
| Authors: | Tu, Chia-Mu1,2 (AUTHOR), Lin, Meng-Hsuan3 (AUTHOR), Liu, Chih-Peng2 (AUTHOR), Chen, Shih-Ta2 (AUTHOR), Liu, Chun-Min2 (AUTHOR), She, Meng-Ping2 (AUTHOR), Wang, Yu-Cheng2 (AUTHOR), Wang, Hsiang-Ching2 (AUTHOR), Chang, Yuan-Chia2 (AUTHOR), Chang, Li-Wen2 (AUTHOR), Lo, Yo-Wen2 (AUTHOR), Lin, Min-Xun2 (AUTHOR), Cheng, Ping-Fu2 (AUTHOR), Cheng, Felice2 (AUTHOR), Chen, Jen-Kun4 (AUTHOR), Meng, Jun-Lun3 (AUTHOR), Wu, Ming-Hsi2 (AUTHOR) rexwu518@itri.org.tw, Su, Yu-Cheng5,6 (AUTHOR) ycsu-johnny@nycu.edu.tw |
| Source: | Scientific Reports. 11/25/2025, Vol. 15 Issue 1, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
